Related Experiment Video
Updated: Jul 27, 2026
08:18
A Model of Chronic Nutrient Infusion in the Rat
Published on: August 14, 2013
[An animal model for testing hypoglycemic and hypolipidemic drugs]
1Institute of Materia Medica, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica
|January 1, 1994
Summary
A novel animal model using alloxan-treated Kunming mice effectively simulates hyperglycemia and hyperlipidemia. This model is valuable for screening new hypoglycemic and hypolipidemic drugs.
Area of Science:
- Pharmacology
- Animal Models
- Metabolic Diseases
Context:
- Hyperglycemia and hyperlipidemia are significant health concerns.
- Developing reliable animal models is crucial for drug discovery.
- Alloxan is a known diabetogenic agent.
Purpose:
- To establish and validate a new animal model for studying hyperglycemia and hyperlipidemia.
- To assess the utility of this model for drug screening.
Summary:
- Normal Kunming mice were treated with alloxan to induce hyperglycemia and hyperlipidemia.
- Blood glucose and serum triglyceride levels were significantly elevated 48 hours post-administration.
- The model demonstrated efficacy in evaluating antihyperglycemic (metformin, RCH) and antihyperlipidemic (clofibrate, fenofibrate) drugs.
Impact:
- This alloxan-induced mouse model provides a robust platform for preclinical testing of drugs targeting metabolic disorders.
- Facilitates the development of novel therapeutic agents for diabetes and dyslipidemia.
